Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

KUHP baru: Seksualitas masih dianggap tabu, pendidikan seks di sekolah terhambat

Ilustrasi pendidikan seks di sekolah.Pixel-Shot/Shutterstock● Dalam KUHAP baru, seksualitas disederhanakan sebagai ancaman moral, belum mendukung pendidikan seks yang komprehensif.● Minimn...

Mengapa film horor mendominasi bahkan menyokong bisnis bioskop daerah?

● Horor merupakan genre yang paling efisien dan berpotensi cuan tinggi.● Genre inilah yang ternyata menopang kelangsungan bisnis bioskop di daerah.● Alhasil, deretan film terlaris na...

BPJS jutaan warga terputus: Tata kelola buruk korbankan pasien dan fasilitas kesehatan

● Pemerintah berjanji tetap melayani dan membiayai peserta BPJS PBI yang mendadak dinonaktifkan selama tiga bulan ke depan.● Buruknya tata kelola antarlembaga tidak bisa seketika menyelesa...